Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
42
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Riebe Michael T | Director | 9 | $0 | $0 | 2023-06-08 |
| Harsch Mutya | Director | 4 | $0 | $0 | 2023-06-08 |
| Shin Nippon Biomedical Laboratories, Ltd. | 10% Owner | 2 | $27.73M | $0 | 2023-06-08 |
| TAKANASHI KEN | Director, 10% Owner | 13 | $23.57M | $0 | 2023-06-08 |
| O'Neil Thomas P. | Chief Financial Officer | 34 | $0 | $245.8K | 2023-06-08 |
| Sandoval Elisabeth | Director | 7 | $0 | $0 | 2023-06-08 |
| Shah Rajeev M. | Director, 10% Owner | 18 | $27.00M | $0 | 2023-06-08 |
| Lukatch Heath | Director | 7 | $0 | $0 | 2023-06-08 |
| Soloway Thomas P | Director | 6 | $0 | $0 | 2023-06-08 |
| Kollins John A | President and CEO | 11 | $0 | $0 | 2023-06-08 |
| Kolchinsky Peter | Other | 9 | $20.00M | $0 | 2023-06-08 |
| KING THOMAS BRAXTON | Director | 9 | $0 | $0 | 2023-06-08 |
| Leonard Braden Michael | 10% Owner | 4 | $4.50M | $0 | 2022-11-21 |
| COMMODORE CAPITAL LP | 10% Owner | 19 | $2.63M | $2.31M | 2022-11-14 |
| ALBRECHT DETLEF | Chief Medical Officer | 39 | $0 | $184.6K | 2022-06-03 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 3 | $0 | $0 | 2021-04-01 |
| Hadley Harbor Master Investors (Cayman) II L.P. | 10% Owner | 2 | $0 | $0 | 2019-09-17 |
| COULTER JAMES G | 10% Owner | 4 | $1.50M | $0 | 2019-09-17 |
| Bresler Joshua D | Director | 8 | $0 | $0 | 2014-04-18 |
| HAUSCHILD STEVEN D | Chief Credit Officer | 21 | $0 | $0 | 2014-04-18 |
| SCHULTHEIS ANDREW J | General Counsel | 27 | $0 | $0 | 2014-04-18 |
| Hartheimer Robert Herman | Director | 11 | $0 | $0 | 2014-04-18 |
| SEIBLY JOHN GREGORY | CEO/President - SFC | 54 | $0 | $0 | 2014-04-18 |
| DONEGAN BOB C | Director | 12 | $0 | $0 | 2014-04-18 |
| Warburg Pincus X Partners, L.P. | Director, 10% Owner | 2 | $0 | $0 | 2014-04-18 |
| BOYER ELLEN RM | Director | 11 | $0 | $0 | 2014-04-18 |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Officer | 24 | $0 | $29.4K | 2014-04-18 |
| Thomas H. Lee Equity Fund VI, L.P. | 10% Owner | 2 | $0 | $0 | 2014-04-18 |
| THL Equity Advisors VI, LLC | 10% Owner | 2 | $0 | $0 | 2014-04-18 |
| Eckhardt Ezra | COO - Sterling Financial Corp. | 52 | $0 | $0 | 2014-04-18 |
| Reuling Michael F | Director | 13 | $0 | $0 | 2014-04-18 |
| EISENHART WILLIAM L | Director | 14 | $0 | $0 | 2014-04-18 |
| THOMAS H. LEE ADVISORS, LLC | 10% Owner | 2 | $0 | $0 | 2014-04-18 |
| POPE MARIA M | Director | 6 | $0 | $0 | 2014-04-18 |
| DEPILLO DAVID S | EVP/Vice Chairman | 24 | $0 | $0 | 2014-04-18 |
| BILLER LESLIE S | Director | 3 | $0 | $0 | 2014-04-18 |
| EDWARDS WEBB | Director | 11 | $0 | $0 | 2014-04-18 |
| RUSNAK PATRICK J | Chief Financial Officer | 21 | $0 | $0 | 2014-04-18 |
| BOGGS PAULA | Director | 6 | $0 | $0 | 2014-04-18 |
| BEHAR HOWARD | Director | 11 | $0 | $0 | 2014-04-18 |
| COULTER DAVID A | Director | 13 | $0 | $0 | 2014-04-18 |
| JAECKEL SCOTT L | Director | 9 | $0 | $0 | 2013-05-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Harsch Mutya | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 40,000 | — | $0 | 0 | SEC↗ |
| Harsch Mutya | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| KING THOMAS BRAXTON | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 10,000 | — | $0 | 0 | SEC↗ |
| KING THOMAS BRAXTON | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 14,893 | — | $0 | 0 | SEC↗ |
| KING THOMAS BRAXTON | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 12,765 | — | $0 | 0 | SEC↗ |
| KING THOMAS BRAXTON | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 12,765 | — | $0 | 0 | SEC↗ |
| KING THOMAS BRAXTON | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| KING THOMAS BRAXTON | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| Lukatch Heath | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| Lukatch Heath | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| Lukatch Heath | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| Kollins John A | President and CEO | D To issuer deriv | 2023-06-08 | 2023-06-08 | 175,000 | — | $0 | 0 | SEC↗ |
| Kollins John A | President and CEO | D To issuer deriv | 2023-06-08 | 2023-06-08 | 505,000 | — | $0 | 0 | SEC↗ |
| Kollins John A | President and CEO | D To issuer deriv | 2023-06-08 | 2023-06-08 | 276,595 | — | $0 | 0 | SEC↗ |
| Kollins John A | President and CEO | D To issuer deriv | 2023-06-08 | 2023-06-08 | 127,659 | — | $0 | 0 | SEC↗ |
| Kollins John A | President and CEO | D To issuer deriv | 2023-06-08 | 2023-06-08 | 127,659 | — | $0 | 0 | SEC↗ |
| Kollins John A | President and CEO | D To issuer deriv | 2023-06-08 | 2023-06-08 | 240,000 | — | $0 | 0 | SEC↗ |
| Kollins John A | President and CEO | D To issuer deriv | 2023-06-08 | 2023-06-08 | 127,659 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| Soloway Thomas P | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| Sandoval Elisabeth | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 14,893 | — | $0 | 0 | SEC↗ |
| Sandoval Elisabeth | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| Sandoval Elisabeth | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| Sandoval Elisabeth | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 10,000 | — | $0 | 0 | SEC↗ |
| Riebe Michael T | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 12,765 | — | $0 | 0 | SEC↗ |
| Riebe Michael T | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| Riebe Michael T | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 14,893 | — | $0 | 0 | SEC↗ |
| Riebe Michael T | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 12,765 | — | $0 | 0 | SEC↗ |
| Riebe Michael T | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| Riebe Michael T | Director | D To issuer deriv | 2023-06-08 | 2023-06-08 | 10,000 | — | $0 | 0 | SEC↗ |
| TAKANASHI KEN | Director, 10% Owner | D To issuer deriv | 2023-06-08 | 2023-06-08 | 10,000 | — | $0 | 0 | SEC↗ |
| TAKANASHI KEN | Director, 10% Owner | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| TAKANASHI KEN | Director, 10% Owner | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | D To issuer deriv | 2023-06-08 | 2023-06-08 | 10,000 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | D To issuer deriv | 2023-06-08 | 2023-06-08 | 30,000 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | D To issuer deriv | 2023-06-08 | 2023-06-08 | 20,000 | — | $0 | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | D To issuer deriv | 2023-06-08 | 2023-06-08 | 60,000 | — | $0 | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | D To issuer deriv | 2023-06-08 | 2023-06-08 | 80,000 | — | $0 | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | D To issuer deriv | 2023-06-08 | 2023-06-08 | 190,000 | — | $0 | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | D To issuer deriv | 2023-06-08 | 2023-06-08 | 76,595 | — | $0 | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | D To issuer deriv | 2023-06-08 | 2023-06-08 | 72,340 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Other | D To issuer deriv | 2023-06-08 | 2023-06-12 | 30,000 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Other | D To issuer deriv | 2023-06-08 | 2023-06-12 | 20,000 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Other | D To issuer deriv | 2023-06-08 | 2023-06-12 | 10,000 | — | $0 | 0 | SEC↗ |
| Shin Nippon Biomedical Laborat | 10% Owner | P Buy | 2023-06-08 | 2023-06-08 | 8,423,732 | $0.91 | $7.67M | 8,423,732 | SEC↗ |
| Kolchinsky Peter | Other | U Tender | 2023-06-08 | 2023-06-12 | 5,914,252 | — | $0 | 0 | SEC↗ |
| Shin Nippon Biomedical Laborat | 10% Owner | P Buy | 2023-06-06 | 2023-06-08 | 22,053,581 | $0.91 | $20.07M | 22,053,581 | SEC↗ |
| Kollins John A | President and CEO | U Tender | 2023-06-06 | 2023-06-08 | 305,911 | $0.91 | $278.4K | 0 | SEC↗ |
| TAKANASHI KEN | Director, 10% Owner | P Buy | 2023-06-06 | 2023-06-08 | 22,053,581 | $0.91 | $20.07M | 24,847,694 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | U Tender | 2023-06-06 | 2023-06-08 | 5,914,252 | $0.91 | $5.38M | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | U Tender | 2023-06-06 | 2023-06-08 | 13,877 | $0.91 | $12.6K | 0 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2022-11-21 | 2022-11-23 | 150,000 | $0.71 | $106.5K | 150,000 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 531,000 | $0.63 | $334.5K | 6,139,306 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2022-11-15 | 2022-11-16 | 300,694 | $0.63 | $189.4K | 6,440,000 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | S Sale | 2022-11-14 | 2022-11-16 | 3,250,000 | $0.71 | $2.31M | 461,286 | SEC↗ |
| Leonard Braden Michael | 10% Owner | P Buy | 2022-11-14 | 2022-11-16 | 5,608,306 | $0.69 | $3.87M | 5,608,306 | SEC↗ |
| TAKANASHI KEN | Director | A Award deriv | 2022-06-03 | 2022-12-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Riebe Michael T | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KING THOMAS BRAXTON | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Harsch Mutya | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| TAKANASHI KEN | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Sandoval Elisabeth | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lukatch Heath | Director | A Award deriv | 2022-06-03 | 2022-06-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kollins John A | President and CEO | A Award deriv | 2022-06-03 | 2022-06-07 | 505,000 | — | $0 | 505,000 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | A Award deriv | 2022-06-03 | 2022-06-07 | 190,000 | — | $0 | 190,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | A Award deriv | 2022-06-03 | 2022-06-07 | 190,000 | — | $0 | 190,000 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-24 | 2021-11-29 | 2,922 | $5.42 | $15.8K | 3,711,286 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-22 | 2021-11-23 | 9,979 | $5.49 | $54.8K | 3,708,364 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-19 | 2021-11-23 | 3,225 | $5.44 | $17.5K | 3,698,385 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-11 | 2021-11-12 | 7,941 | $6.05 | $48.0K | 3,695,160 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-10 | 2021-11-12 | 9,622 | $5.85 | $56.3K | 3,687,219 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-08 | 2021-11-10 | 560 | $5.99 | $3.4K | 3,677,597 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-05 | 2021-11-08 | 7,800 | $5.95 | $46.4K | 3,677,037 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-04 | 2021-11-08 | 1,400 | $5.88 | $8.2K | 3,669,237 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-11-02 | 2021-11-04 | 8,880 | $5.64 | $50.1K | 3,667,837 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-29 | 2021-11-02 | 44,651 | $5.71 | $255.0K | 3,658,957 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-28 | 2021-10-29 | 15,082 | $5.55 | $83.7K | 3,614,306 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-27 | 2021-10-29 | 39,581 | $5.45 | $215.7K | 3,599,224 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-22 | 2021-10-25 | 27,629 | $5.51 | $152.2K | 3,559,643 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-21 | 2021-10-25 | 32,816 | $5.40 | $177.2K | 3,532,014 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-20 | 2021-10-21 | 40,663 | $5.44 | $221.2K | 3,499,198 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-19 | 2021-10-21 | 87,580 | $5.07 | $444.0K | 3,458,535 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-18 | 2021-10-19 | 36,194 | $4.87 | $176.3K | 3,370,955 | SEC↗ |
| COMMODORE CAPITAL LP | 10% Owner | P Buy | 2021-10-15 | 2021-10-19 | 126,000 | $4.83 | $608.6K | 3,334,761 | SEC↗ |
| Harsch Mutya | Director | A Award deriv | 2021-10-11 | 2021-10-12 | 40,000 | — | $0 | 40,000 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | J Other | 2021-04-01 | 2021-04-05 | 566,011 | $5.91 | $3.35M | 566,011 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | J Other | 2021-04-01 | 2021-04-05 | 192,387 | $5.91 | $1.14M | 5,348,241 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | P Buy | 2021-02-26 | 2021-03-02 | 1,232,394 | $5.68 | $7.00M | 5,155,854 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | A Award deriv | 2020-12-03 | 2020-12-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Kollins John A | President and CEO | A Award deriv | 2020-12-03 | 2020-12-07 | 240,000 | — | $0 | 240,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | A Award deriv | 2020-12-03 | 2020-12-07 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Sandoval Elisabeth | Director | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Lukatch Heath | Director | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TAKANASHI KEN | Director | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Riebe Michael T | Director | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KING THOMAS BRAXTON | Director | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award deriv | 2020-12-03 | 2020-12-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise deriv | 2020-09-01 | 2020-09-03 | 750 | — | $0 | 65,590 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-09-01 | 2020-09-03 | 1,000 | — | $0 | 67,468 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-09-01 | 2020-09-03 | 750 | $22.19 | $16.6K | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-09-01 | 2020-09-03 | 750 | $4.56 | $3.4K | 750 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-09-01 | 2020-09-03 | 1,000 | $22.21 | $22.2K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-09-01 | 2020-09-03 | 1,000 | $4.56 | $4.6K | 21,212 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise deriv | 2020-08-05 | 2020-08-07 | 1,000 | — | $0 | 66,340 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-08-05 | 2020-08-07 | 1,000 | $4.56 | $4.6K | 1,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-08-05 | 2020-08-07 | 1,000 | $25.00 | $25.0K | 0 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-08-03 | 2020-08-05 | 1,000 | — | $0 | 68,468 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-08-03 | 2020-08-05 | 200 | $23.12 | $4.6K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-08-03 | 2020-08-05 | 200 | $4.56 | $912 | 20,412 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-08-03 | 2020-08-05 | 800 | $4.56 | $3.6K | 21,012 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-08-03 | 2020-08-05 | 800 | $22.85 | $18.3K | 20,212 | SEC↗ |
| Soloway Thomas P | Director | A Award deriv | 2020-07-02 | 2020-07-07 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-07-01 | 2020-07-02 | 1,000 | — | $0 | 69,468 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise deriv | 2020-07-01 | 2020-07-02 | 1,000 | — | $0 | 67,340 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-07-01 | 2020-07-02 | 300 | $4.56 | $1.4K | 20,512 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-07-01 | 2020-07-02 | 300 | $25.69 | $7.7K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-07-01 | 2020-07-02 | 600 | $4.56 | $2.7K | 20,812 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-07-01 | 2020-07-02 | 600 | $26.99 | $16.2K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-07-01 | 2020-07-02 | 100 | $4.56 | $456 | 20,312 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-07-01 | 2020-07-02 | 100 | $27.81 | $2.8K | 20,212 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-07-01 | 2020-07-02 | 394 | $4.56 | $1.8K | 394 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-07-01 | 2020-07-02 | 300 | $4.56 | $1.4K | 300 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-07-01 | 2020-07-02 | 300 | $25.63 | $7.7K | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-07-01 | 2020-07-02 | 394 | $26.70 | $10.5K | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-07-01 | 2020-07-02 | 306 | $27.59 | $8.4K | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-07-01 | 2020-07-02 | 306 | $4.56 | $1.4K | 306 | SEC↗ |
| Lukatch Heath | Director | A Award deriv | 2020-06-29 | 2020-06-30 | 20,000 | — | $0 | 20,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise deriv | 2020-06-23 | 2020-06-24 | 2,115 | — | $0 | 74,480 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-06-23 | 2020-06-24 | 2,115 | $35.23 | $74.5K | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-06-23 | 2020-06-24 | 2,115 | $1.04 | $2.2K | 2,115 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TAKANASHI KEN | Director | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KING THOMAS BRAXTON | Director | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Lukatch Heath | Director | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Sandoval Elisabeth | Director | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Riebe Michael T | Director | A Award deriv | 2020-06-12 | 2020-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise deriv | 2020-06-01 | 2020-06-02 | 1,000 | — | $0 | 68,340 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-06-01 | 2020-06-02 | 1,000 | — | $0 | 70,468 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-06-01 | 2020-06-02 | 1,000 | $25.32 | $25.3K | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-06-01 | 2020-06-02 | 1,000 | $4.56 | $4.6K | 1,000 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-06-01 | 2020-06-02 | 1,000 | $25.26 | $25.3K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-06-01 | 2020-06-02 | 1,000 | $4.56 | $4.6K | 21,212 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise deriv | 2020-05-20 | 2020-05-21 | 2,000 | — | $0 | 69,340 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-05-20 | 2020-05-21 | 2,000 | $4.56 | $9.1K | 2,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-05-20 | 2020-05-21 | 2,000 | $25.00 | $50.0K | 0 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-05-05 | 2020-05-06 | 1,000 | — | $0 | 71,468 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-05-05 | 2020-05-06 | 1,000 | $4.56 | $4.6K | 21,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-05-05 | 2020-05-06 | 1,000 | $20.00 | $20.0K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-04-14 | 2020-04-16 | 800 | — | $0 | 72,468 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-04-14 | 2020-05-06 | 800 | — | $0 | 72,468 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-04-14 | 2020-04-16 | 800 | $20.00 | $16.0K | 20,012 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-04-14 | 2020-04-16 | 800 | $4.56 | $3.6K | 20,812 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-04-14 | 2020-05-06 | 800 | $4.56 | $3.6K | 21,012 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-04-14 | 2020-05-06 | 800 | $20.00 | $16.0K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-04-01 | 2020-04-03 | 200 | — | $0 | 73,268 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale deriv | 2020-04-01 | 2020-05-06 | 200 | — | $0 | 73,268 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-04-01 | 2020-04-03 | 200 | $20.25 | $4.0K | 20,012 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-04-01 | 2020-04-03 | 200 | $4.56 | $912 | 20,412 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-04-01 | 2020-05-06 | 200 | $20.25 | $4.0K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-04-01 | 2020-05-06 | 200 | $4.56 | $912 | 20,412 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise deriv | 2020-03-11 | 2020-03-12 | 1,000 | — | $0 | 71,340 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise deriv | 2020-03-11 | 2020-03-12 | 1,000 | — | $0 | 73,468 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | S Sale | 2020-03-11 | 2020-03-12 | 1,000 | $27.68 | $27.7K | 0 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | M Exercise | 2020-03-11 | 2020-03-12 | 1,000 | $4.56 | $4.6K | 1,000 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | S Sale | 2020-03-11 | 2020-03-12 | 1,000 | $27.42 | $27.4K | 20,212 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | M Exercise | 2020-03-11 | 2020-03-12 | 1,000 | $4.56 | $4.6K | 21,212 | SEC↗ |
| Kollins John A | President and CEO | A Award deriv | 2020-03-04 | 2020-03-06 | 175,000 | — | $0 | 175,000 | SEC↗ |
| O'Neil Thomas P. | Chief Financial Officer | A Award deriv | 2020-03-04 | 2020-03-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ALBRECHT DETLEF | Chief Medical Officer | A Award deriv | 2020-03-04 | 2020-03-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| TAKANASHI KEN | Director | C Conversion deriv | 2019-09-17 | 2019-09-17 | 33,741 | — | $0 | 0 | SEC↗ |
| TAKANASHI KEN | Director | C Conversion deriv | 2019-09-17 | 2019-09-17 | 307,110 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-17 | 365,530 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-17 | 1,642,879 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-17 | 1,139,635 | — | $0 | 0 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-17 | 200,481 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-17 | 2,008,409 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-17 | 1,340,116 | — | $0 | 0 | SEC↗ |
| Hadley Harbor Master Investors | 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-17 | 1,105,154 | — | $0 | 0 | SEC↗ |
| COULTER JAMES G | 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-18 | 1,004,205 | — | $0 | 0 | SEC↗ |
| COULTER JAMES G | 10% Owner | C Conversion deriv | 2019-09-17 | 2019-09-18 | 781,734 | — | $0 | 0 | SEC↗ |
| TAKANASHI KEN | Director | P Buy | 2019-09-17 | 2019-09-17 | 233,333 | $15.00 | $3.50M | 1,561,719 | SEC↗ |
| TAKANASHI KEN | Director | C Conversion | 2019-09-17 | 2019-09-17 | 307,110 | — | $0 | 1,328,386 | SEC↗ |
| TAKANASHI KEN | Director | C Conversion | 2019-09-17 | 2019-09-17 | 33,741 | — | $0 | 1,021,276 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | P Buy | 2019-09-17 | 2019-09-17 | 192,387 | $15.00 | $2.89M | 4,681,858 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | P Buy | 2019-09-17 | 2019-09-17 | 1,140,946 | $15.00 | $17.11M | 4,489,471 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion | 2019-09-17 | 2019-09-17 | 200,481 | — | $0 | 3,348,525 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion | 2019-09-17 | 2019-09-17 | 365,530 | — | $0 | 3,148,044 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion | 2019-09-17 | 2019-09-17 | 1,139,635 | — | $0 | 2,782,514 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | C Conversion | 2019-09-17 | 2019-09-17 | 1,642,879 | — | $0 | 1,642,879 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion | 2019-09-17 | 2019-09-17 | 1,340,116 | — | $0 | 3,348,525 | SEC↗ |
| Kolchinsky Peter | 10% Owner | C Conversion | 2019-09-17 | 2019-09-17 | 2,008,409 | — | $0 | 2,008,409 | SEC↗ |
| Kolchinsky Peter | 10% Owner | P Buy | 2019-09-17 | 2019-09-17 | 1,333,333 | $15.00 | $20.00M | 4,681,858 | SEC↗ |
| Hadley Harbor Master Investors | 10% Owner | C Conversion | 2019-09-17 | 2019-09-17 | 1,105,154 | — | $0 | 1,105,154 | SEC↗ |
| COULTER JAMES G | 10% Owner | P Buy | 2019-09-17 | 2019-09-18 | 100,000 | $15.00 | $1.50M | 1,885,939 | SEC↗ |
| COULTER JAMES G | 10% Owner | C Conversion | 2019-09-17 | 2019-09-18 | 1,785,939 | — | $0 | 1,785,939 | SEC↗ |
| THOMAS H. LEE ADVISORS, LLC | 10% Owner | J Other deriv | 2014-04-18 | 2014-04-22 | 1,480,119 | — | $0 | 0 | SEC↗ |
| Bresler Joshua D | Director | J Other deriv | 2014-04-18 | 2014-04-22 | 1,480,119 | — | $0 | 0 | SEC↗ |
| Thomas H. Lee Equity Fund VI, | 10% Owner | J Other deriv | 2014-04-18 | 2014-04-22 | 815,617 | — | $0 | 0 | SEC↗ |
| THL Equity Advisors VI, LLC | 10% Owner | J Other deriv | 2014-04-18 | 2014-04-22 | 1,480,119 | — | $0 | 0 | SEC↗ |
| Warburg Pincus X Partners, L.P | Director, 10% Owner | J Other deriv | 2014-04-18 | 2014-04-22 | 1,480,119 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer deriv | 2014-04-18 | 2014-04-22 | 24,543 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer deriv | 2014-04-18 | 2014-04-22 | 455 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer deriv | 2014-04-18 | 2014-04-22 | 20,680 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer deriv | 2014-04-18 | 2014-04-22 | 19,702 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer deriv | 2014-04-18 | 2014-04-22 | 15,784 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer deriv | 2014-04-18 | 2014-04-22 | 7,018 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer deriv | 2014-04-18 | 2014-04-22 | 8,823 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,185 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer deriv | 2014-04-18 | 2014-04-22 | 8,406 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer deriv | 2014-04-18 | 2014-04-22 | 9,771 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer deriv | 2014-04-18 | 2014-04-22 | 11,224 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer deriv | 2014-04-18 | 2014-04-22 | 19,385 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer deriv | 2014-04-18 | 2014-04-22 | 1,387 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,473 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer deriv | 2014-04-18 | 2014-04-22 | 6,304 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer deriv | 2014-04-18 | 2014-04-22 | 6,013 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer deriv | 2014-04-18 | 2014-04-22 | 6,734 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer deriv | 2014-04-18 | 2014-04-22 | 6,617 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer deriv | 2014-04-18 | 2014-04-22 | 9,771 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer deriv | 2014-04-18 | 2014-04-22 | 13,469 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer deriv | 2014-04-18 | 2014-04-22 | 8,231 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer deriv | 2014-04-18 | 2014-04-22 | 3,746 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer deriv | 2014-04-18 | 2014-04-22 | 8,639 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 6,013 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 6,285 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 5,735 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 61 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 5,464 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 1,249 | — | $0 | 0 | SEC↗ |
| RUSNAK PATRICK J | Chief Financial Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 7,005 | — | $0 | 0 | SEC↗ |
| RUSNAK PATRICK J | Chief Financial Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,810 | — | $0 | 0 | SEC↗ |
| RUSNAK PATRICK J | Chief Financial Officer | D To issuer deriv | 2014-04-18 | 2014-04-22 | 7,352 | — | $0 | 0 | SEC↗ |
| Reuling Michael F | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,626 | — | $0 | 0 | SEC↗ |
| Reuling Michael F | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 149 | — | $0 | 0 | SEC↗ |
| Reuling Michael F | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 31 | — | $0 | 0 | SEC↗ |
| DONEGAN BOB C | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 31 | — | $0 | 0 | SEC↗ |
| DONEGAN BOB C | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,626 | — | $0 | 0 | SEC↗ |
| Hartheimer Robert Herman | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,626 | — | $0 | 0 | SEC↗ |
| POPE MARIA M | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 1,817 | — | $0 | 0 | SEC↗ |
| EDWARDS WEBB | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,626 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,244 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | D To issuer deriv | 2014-04-18 | 2014-04-22 | 751 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,895 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | D To issuer deriv | 2014-04-18 | 2014-04-22 | 76 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | D To issuer deriv | 2014-04-18 | 2014-04-22 | 1,061 | — | $0 | 0 | SEC↗ |
| BOYER ELLEN RM | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,626 | — | $0 | 0 | SEC↗ |
| BOGGS PAULA | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 1,817 | — | $0 | 0 | SEC↗ |
| BILLER LESLIE S | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 141,044 | — | $0 | 0 | SEC↗ |
| BEHAR HOWARD | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,626 | — | $0 | 0 | SEC↗ |
| EISENHART WILLIAM L | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 46 | — | $0 | 0 | SEC↗ |
| EISENHART WILLIAM L | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 2,626 | — | $0 | 0 | SEC↗ |
| EISENHART WILLIAM L | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 31 | — | $0 | 0 | SEC↗ |
| EISENHART WILLIAM L | Director | D To issuer deriv | 2014-04-18 | 2014-04-22 | 31 | — | $0 | 0 | SEC↗ |
| COULTER DAVID A | Director | J Other deriv | 2014-04-18 | 2014-04-23 | 2,626 | — | $0 | 0 | SEC↗ |
| COULTER DAVID A | Director | J Other deriv | 2014-04-18 | 2014-04-23 | 1,480,119 | — | $0 | 0 | SEC↗ |
| THOMAS H. LEE ADVISORS, LLC | 10% Owner | J Other | 2014-04-18 | 2014-04-22 | 12,954,788 | — | $0 | 0 | SEC↗ |
| Thomas H. Lee Equity Fund VI, | 10% Owner | J Other | 2014-04-18 | 2014-04-22 | 7,134,979 | — | $0 | 0 | SEC↗ |
| Bresler Joshua D | Director | J Other | 2014-04-18 | 2014-04-22 | 12,954,788 | — | $0 | 0 | SEC↗ |
| THL Equity Advisors VI, LLC | 10% Owner | J Other | 2014-04-18 | 2014-04-22 | 12,948,112 | — | $0 | 0 | SEC↗ |
| Warburg Pincus X Partners, L.P | Director, 10% Owner | J Other | 2014-04-18 | 2014-04-22 | 12,948,107 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer | 2014-04-18 | 2014-04-22 | 80,427 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer | 2014-04-18 | 2014-04-22 | 2,631 | — | $0 | 0 | SEC↗ |
| SEIBLY JOHN GREGORY | CEO/President - SFC | D To issuer | 2014-04-18 | 2014-04-22 | 294 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer | 2014-04-18 | 2014-04-22 | 237,273 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer | 2014-04-18 | 2014-04-22 | 17,116 | — | $0 | 0 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | D To issuer | 2014-04-18 | 2014-04-22 | 41 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer | 2014-04-18 | 2014-04-22 | 5,211 | — | $0 | 0 | SEC↗ |
| SCHULTHEIS ANDREW J | General Counsel | D To issuer | 2014-04-18 | 2014-04-22 | 1,422 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer | 2014-04-18 | 2014-04-22 | 1,468 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer | 2014-04-18 | 2014-04-22 | 74,046 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer | 2014-04-18 | 2014-04-22 | 925 | — | $0 | 0 | SEC↗ |
| Eckhardt Ezra | COO - Sterling Financial Cor | D To issuer | 2014-04-18 | 2014-04-22 | 13,340 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer | 2014-04-18 | 2014-04-22 | 15,136 | — | $0 | 0 | SEC↗ |
| HAUSCHILD STEVEN D | Chief Credit Officer | D To issuer | 2014-04-18 | 2014-04-22 | 487 | — | $0 | 0 | SEC↗ |
| RUSNAK PATRICK J | Chief Financial Officer | D To issuer | 2014-04-18 | 2014-04-22 | 14,232 | — | $0 | 0 | SEC↗ |
| RUSNAK PATRICK J | Chief Financial Officer | D To issuer | 2014-04-18 | 2014-04-22 | 14 | — | $0 | 0 | SEC↗ |
| RUSNAK PATRICK J | Chief Financial Officer | D To issuer | 2014-04-18 | 2014-04-22 | 1,151 | — | $0 | 0 | SEC↗ |
| Reuling Michael F | Director | D To issuer | 2014-04-18 | 2014-04-22 | 9,197 | — | $0 | 0 | SEC↗ |
| DONEGAN BOB C | Director | D To issuer | 2014-04-18 | 2014-04-22 | 8,013 | — | $0 | 0 | SEC↗ |
| Hartheimer Robert Herman | Director | D To issuer | 2014-04-18 | 2014-04-22 | 29,711 | — | $0 | 0 | SEC↗ |
| POPE MARIA M | Director | D To issuer | 2014-04-18 | 2014-04-22 | 1,169 | — | $0 | 0 | SEC↗ |
| EDWARDS WEBB | Director | D To issuer | 2014-04-18 | 2014-04-22 | 6,981 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | D To issuer | 2014-04-18 | 2014-04-22 | 3,926 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | D To issuer | 2014-04-18 | 2014-04-22 | 168 | — | $0 | 0 | SEC↗ |
| BOYER ELLEN RM | Director | D To issuer | 2014-04-18 | 2014-04-22 | 7,134 | — | $0 | 0 | SEC↗ |
| BOGGS PAULA | Director | D To issuer | 2014-04-18 | 2014-04-22 | 1,169 | — | $0 | 0 | SEC↗ |
| BILLER LESLIE S | Director | D To issuer | 2014-04-18 | 2014-04-22 | 530,304 | — | $0 | 0 | SEC↗ |
| BEHAR HOWARD | Director | D To issuer | 2014-04-18 | 2014-04-22 | 56,981 | — | $0 | 0 | SEC↗ |
| EISENHART WILLIAM L | Director | D To issuer | 2014-04-18 | 2014-04-22 | 17,088 | — | $0 | 0 | SEC↗ |
| COULTER DAVID A | Director | J Other | 2014-04-18 | 2014-04-23 | 12,948,107 | — | $0 | 0 | SEC↗ |
| COULTER DAVID A | Director | J Other | 2014-04-18 | 2014-04-23 | 6,981 | — | $0 | 0 | SEC↗ |
| Bresler Joshua D | Director | J Other | 2014-04-17 | 2014-04-18 | 1,303 | — | $0 | 12,954,788 | SEC↗ |
| Bresler Joshua D | Director | J Other | 2014-04-17 | 2014-04-18 | 1,303 | — | $0 | 0 | SEC↗ |
| BUTTERFIELD ROBERT G | Controller/Prin. Acct. Offic | A Award deriv | 2014-04-04 | 2014-04-08 | 751 | — | $0 | 751 | SEC↗ |
| DEPILLO DAVID S | EVP/Vice Chairman | A Award deriv | 2014-04-04 | 2014-04-08 | 9,771 | — | $0 | 9,771 | SEC↗ |